Phys Vivas · endocrine
Metabolic Bone Disease AND Vitamin D Disorders — Viva Defence
DCE viva defence for Metabolic Bone Disease AND Vitamin D Disorders.
On this page & tools
Target exams
Metabolic Bone Disease AND Vitamin D Disorders Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Metabolic Bone Disease AND Vitamin D Disorders. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
Short case
Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]
References
- [1]Amouroux C, Porquet-Bordes V, Adler E, Goff YL, et al. French national diagnosis and care protocol (PNDS) for infantile idiopathic hypercalcemia (IIH) Orphanet J Rare Dis, 2026.PMID 42469912
- [2]Zhuang J, Su D, Gao Q, Hu L, et al. Evaluating combined acupuncture and antiresorptive therapy in Chinese women with postmenopausal osteoporosis: a systematic review and network meta-analysis Front Endocrinol (Lausanne), 2026.PMID 42460309
- [3]Yang R, Zeng H, Xiao Q, Xie Y, et al. Endocrine‑metabolic imbalance drives osteoarthritis: From whole‑joint pathobiology to precision therapy (Review) Int J Mol Med, 2026.PMID 42429052
- [4]Premikha M, Ricci V, Kan SJ, Expert Group of the Osteoporosis ACG, et al. Translating evidence into primary care: Singapore's 2025 national osteoporosis guideline and a multilevel framework for assessing guideline impact in mixed health systems Fam Med Community Health, 2026.PMID 42399071
- [5]Sidbury R, Alikhan A, Bercovitch L, Cohen DE, et al. Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis J Am Acad Dermatol, 2026.PMID 41949509
- [6]Sosa-Henríquez M, Torregrosa-Suau Ó, Gómez de Tejada-Romero MJ, Cancelo-Hidalgo MJ, et al. Rethinking Vitamin D Deficiency: Controversies and Practical Guidance for Clinical Management Nutrients, 2025.PMID 41305623
- [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922